# Integrative "Omics" Approaches for Leukemia Target Identification and Matched Therapeutic Intervention

> **NCT06626893** · NA · RECRUITING · sponsor: **Azienda Ospedaliero-Universitaria di Parma** · enrollment: 100 (estimated)

## Conditions studied

- Myeloid Leukemia, Acute
- Leukemia, Acute Lymphoblastic

## Interventions

- **BIOLOGICAL:** Functional tests
- **GENETIC:** Next Generation Sequencing analysis
- **BIOLOGICAL:** Microvesicles analysis

## Key facts

- **NCT ID:** NCT06626893
- **Lead sponsor:** Azienda Ospedaliero-Universitaria di Parma
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-01
- **Primary completion:** 2025-03-01
- **Final completion:** 2025-03-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06626893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06626893, "Integrative "Omics" Approaches for Leukemia Target Identification and Matched Therapeutic Intervention". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06626893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*